Eisai Co. Ltd.

In News

WashU Medicine Honors CEO Haruo Naito and Eisai for Longstanding Contributions to Alzheimer’s Disease Research and Healthcare | News ReleaseNews Release：2026 | Eisai Co., Ltd. - Eisai

Eisai - Aug 18, 2026

LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment - Biogen

Biogen - Jul 14, 2026

Eisai and Biogen Launch LEQEMBI IQLIK Subcutaneous Injection for Early Alzheimer’s Disease in the U.S. - Quiver Quantitative

Quiver Quantitative - Aug 24, 2026

Eisai Co., Ltd. 2027 Q1 - Results - Earnings Call Presentation (OTCMKTS:ESAIY) 2026-08-03 - Seeking Alpha

Seeking Alpha - Aug 03, 2026

Eisai Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT Infrastructure Operations and Digital Transformation | News ReleaseNews Release：2026 | Eisai Co., Ltd. - Eisai

Eisai - Mar 17, 2026

FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug - Reuters

Reuters - Jul 13, 2026

Earnings call transcript: Eisai Q4 2025 reports record revenue but profit declines - Investing.com

Investing.com - May 15, 2026

EISAI TO BEGIN ENROLLING PHASE 2 STUDY IN PATIENTS WITH NARCOLEPSY - PR Newswire

PR Newswire - Mar 26, 2026

Eisai Co Ltd Receives Orphan Drug Designation In Japan For Novel Orexin 2 Receptor Agonist E2086 - BioPharma APAC

BioPharma APAC - Feb 17, 2026

Eisai Selected for “SOMPO Sustainability Index” for FY2026 - Eisai

Eisai - Jul 06, 2026

Eisai strikes Japan licensing deal with Shanghai Henlius Biotech - Reuters

Reuters - Feb 05, 2026

Earnings call transcript: Eisai Q1 2026 beats revenue forecast, stock slips 3.6% - Investing.com

Investing.com - Aug 03, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment